Project Number 5R43AG029670-02 Agency/Funding Organization NIA Funding Year 2008 View Full Project Details for LEPTIN AS A THERAPY FOR ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator TEZAPSIDIS, NIKOLAOS Principal Investigator First Name NIKOLAOS Principal Investigator Last Name TEZAPSIDIS Awardee Organization NEUROTEZ, INC. Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement PA-06-027: PHARMACOLOGIC AGENTS AND DRUGS FOR MENTAL DISORDERS (SBIR [R43/R44]) FY Overall Cost $386,097 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Repository [AlzPED] Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease
